Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAMINA-HeFT: Darbepoetin Alfa in Heart Failure
NCT00049985Phase 2Completed
- Sponsor
- Amgen
- Start
- Jul 2002
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
Phase 2, randomised, double-blind trial in anemia comparing Darbepoetin Alfa with Placebo (2 arms). Primary endpoint: Exercise Tolerance (Treadmill Exercise Time) at 27 weeks. Started Jul 2002; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00049985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049985.